Madrigal Pharmaceuticals, Inc. (MDGL)
Madrigal Pharmaceuticals, Inc. (MDGL) is a healthcare company (biotechnology) based in the United States. The share price is $426.40, up 0.58% on the day, which values the company at $9.91B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.
Key facts
- Share price
- $426.40+0.58% today
- Market value
- $9.91B
- Forward P/E
- 41.1×
- 200-week average
- $335.2727% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Madrigal Pharmaceuticals, Inc. in more detail
MDGL trades at 41.1× next year's expected earnings, 6.9× sales. It sits 27% above its 200-week average of $335.27.
In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Beneish M-score flags the accounts; Weak Piotroski score.
5 of the superinvestors tracked here hold MDGL, including John Paulson (27.9% of the portfolio), Julian and Felix Baker (5.8% of the portfolio), Brandon Haley (0.2% of the portfolio).
Superinvestors holding MDGL
5 of the investors tracked here report a position in their latest 13F filing.
- John Paulson Paulson & Co.27.9% of portfolio · $719.5M · trimmed · Q2 2026
- Julian and Felix Baker Baker Bros. Advisors5.77% of portfolio · $1.2B · added · Q2 2026
- Brandon Haley Holocene Advisors0.19% of portfolio · $82.1M · new · Q2 2026
- Takis Sparaggis Alkeon Capital Management0.17% of portfolio · $40.3M · Q3 2026
- Ken Griffin Citadel Advisors0.16% of portfolio · $272.4M · added · Q2 2026
Health Care companies of similar size
- Ensign GroupENSG
- VaxcytePCVX
- Bio-Rad LaboratoriesBIO
- Molina HealthcareMOH
- Spyre TherapeuticsSYRE
- QiagenQGEN
- InsuletPODD
- BrukerBRKR
- Globus MedicalGMED
- Henry ScheinHSIC
- Oscar HealthOSCR
- TG TherapeuticsTGTX
Side by side:MDGL vs GMED (Madrigal Pharmaceuticals, Inc. vs Globus Medical)MDGL vs BRKR (Madrigal Pharmaceuticals, Inc. vs Bruker)MDGL vs HSIC (Madrigal Pharmaceuticals, Inc. vs Henry Schein)MDGL vs PODD (Madrigal Pharmaceuticals, Inc. vs Insulet)MDGL vs QGEN (Madrigal Pharmaceuticals, Inc. vs Qiagen)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
Madrigal Pharmaceuticals, Inc. (MDGL): questions and answers
What is Madrigal Pharmaceuticals, Inc.'s market cap?
Madrigal Pharmaceuticals, Inc. is valued at $9.91B at a share price of $426.40.
Is MDGL above its 200-week moving average?
Yes. MDGL is 27.2% above its 200-week average of $335.27. Long-term investors watch that line because strong companies rarely trade below it for long.
Does MDGL pay a dividend?
Madrigal Pharmaceuticals, Inc. does not currently pay a regular dividend.
Which famous investors own MDGL?
In their latest quarterly filings, John Paulson (27.9% of the portfolio), Julian and Felix Baker (5.8% of the portfolio), Brandon Haley (0.2% of the portfolio), Takis Sparaggis (0.2% of the portfolio), Ken Griffin (0.2% of the portfolio) hold MDGL. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Madrigal Pharmaceuticals, Inc. (MDGL) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/MDGL
Underlying data: Yahoo Finance; company filings with the SEC.